- Home
- GWRE vs QGEN Comparison
GWRE vs QGEN Comparison
Compare GWRE & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GWRE | QGEN |
|---|---|---|
| Founded | 2001 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 10.2B |
| IPO Year | 2011 | 1998 |
Fundamental Metrics
Financial Performance| Metric | GWRE | QGEN |
|---|---|---|
| Price | $143.25 | $41.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 8 |
| Target Price | ★ $251.31 | $50.26 |
| AVG Volume (30 Days) | 1.1M | ★ 1.3M |
| Earning Date | 06-02-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 5.87% |
| EPS Growth | ★ 1257.14 | N/A |
| EPS | ★ 1.06 | N/A |
| Revenue | ★ $719,514,000.00 | N/A |
| Revenue This Year | $22.42 | $8.18 |
| Revenue Next Year | $15.76 | $5.71 |
| P/E Ratio | $135.00 | ★ $24.01 |
| Revenue Growth | ★ 8.84 | N/A |
| 52 Week Low | $115.57 | $38.80 |
| 52 Week High | $272.60 | $57.82 |
Technical Indicators
Market Signals| Indicator | GWRE | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 51.04 | 44.85 |
| Support Level | $142.86 | $38.80 |
| Resistance Level | $167.31 | $48.53 |
| Average True Range (ATR) | 7.93 | 0.79 |
| MACD | 0.40 | 0.34 |
| Stochastic Oscillator | 74.49 | 53.32 |
Price Performance
Historical ComparisonAbout GWRE Guidewire Software Inc.
Guidewire Software provides cloud-based software solutions for property and casualty insurers. The flagship product, InsuranceSuite is a system of record and comprises ClaimCenter, a claims management system; PolicyCenter, a policy management system including policy definitions, quotas, issuance, maintenance, and renewal; and BillingCenter, for billing management, payment plans, and agent commissions. The company also offers InsuranceNow, a midmarket offering, as well as a variety of other add-on applications and services.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).